Abstract
Introduction. Atherogenic index of plasma (AIP) is a logarithmic calculation of the ratio of triglycerides to HDL cholesterol as a marker of lipid profile abnormalities. In COVID-19 patients with comorbid type 2 diabetes mellitus (T2DM), higher AIP tend to worsen the patient conditions. This study aims to assess the correlation between AIP and length of stay (LOS) in COVID-19 patients with T2DM.Methods. An analytical observational study with a cross-sectional approach was conducted among COVID-19 patients with comorbid T2DM. Data were collected from online medical records of confirmed COVID-19 patients with comorbid T2DM who were treated at Sanglah Hospital Denpasar during the period August 1-December 31, 2021. Patients who were <18 years old and did not have lipid profile data during>treatment, were excluded from this study.Results. There were 83 data samples that met the study criteria. The median age of the patients was 64 (23- 91) years, the majority were male (59%; n=49), and 30 patients died during treatment (36.1%). The median LOS for all patients was 10 (1-26) days. Patients with prolonged LOS (≥10 days) had higher triglyceride levels (171.8 vs. 120 mg/dL; p<0.001) and AIP values (0.442 vs. 0.286; p=0.02). There was a strong relationship between AIP and LOS values in COVID-19 patients with T2DM (r=0.632; p<0.001). The AIP value can well-discriminated in prolonged LOS conditions (AUC=0.883; 95%CI 0.792-0.974) with the optimal cut-off value of 0.3045 (sensitivity 75.9% and specificity 83.3%).Conclusion. AIP is correlated with prolonged LOS in COVID-19 patients with T2DM. Holistic management of COVID-19 patients with T2DM is urgently needed, including lipid profile control.
References
1. Zhang Y, Cui Y, Shen M, Zhang J, Liu B, Dai M, et al. Association of diabetes mellitus with disease severity and prognosis in COVID-19: a retrospective cohort study. Diabetes Res Clin Pract. 2020;165:108227.2. Muniyappa R, Gubbi S. COVID-19 pandemic, coronaviruses, and diabetes mellitus. Am J Physiol Endocrinol Metab. 2020;318(5):E736-41.3. Kumar A, Arora A, Sharma P, Anikhindi SA, Bansal N, Singla V, et al. Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis. Diabetes Metab Syndr Res Rev. 2020;14(4):535-45.4. Dobiášová, M. Atherogenic impact of lecithin-cholesterol acyltransferase and its relation to cholesterol esterification rate in HDL (FER (HDL)) and AIP [log (TG/HDL-C)] biomarkers: the butterfly effect. Physiol Res. 2017;66(2):193-203. 5. Hussein TA, Al-Rubaei ZM. Atherogenic index of plasma levels in patients with diabetic and neurodiabetic. Kufa J Nurs Sci. 2016;6(2):1-7.6. Betaubun AM, Bahrun U, Pakasi R. Indeks aterogenik plasma di penyakit diabetes melitus tipe 2. Indones J Clinical Pathol Med Laboratory. 2018;22(1):82-6.7. Simanjuntak SK, Wande IN, Wirawati IA. Correlation between very low-density lipoprotein and trygliseride with glycated hemoglobin levels in type 2 diabetes mellitus patients Indones J Clinical Pathol Med Laboratory. 2021;28(1):51-4.8. Prabandari NP, Wirawati IA, Mahartini NN. Relationship between atherogenic index of plasma with HbA1c levels in type 2 diabetes mellitus patients. Indones J Clinical Pathol Med Laboratory. 2021;28(1):71-4.9. Cibickova L, Karásek D, Langová K, Vaverková H, Orság J, Lukes J, et al. Correlation of lipid parameters and markers of insulin resistance: does smoking make a difference? Physiol Res. 2014;63: S387.10. Nimmanapalli HD, Kasi AD, Devapatla P, Nuttakki V. Lipid ratios, atherogenic coefficient and atherogenic index of plasma as parameters in assessing cardiovascular risk in type 2 diabetes mellitus. Int J Res Med Sci. 2016;4(7):2863-9.11. Al-Mahmood AK, Afrin SF, Hoque N. Dyslipidemia in insulin resistance: cause or effect. Bangladesh J Med Biochem. 2014;7(1):27-31. 12. Cibickova, Karásek D, Langová K, Vaverková H, Orság J, Lukes J, et al. Correlation of lipid parameters and markers of insulin resistance: does smoking make a difference? Physiol Res. 2014;63:S387.13. Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. COVID-19 Research Consortium: Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020;323(20):2052-9.14. Mantovani A, Byrne CD, Zheng MH, Targher G. Diabetes as a risk factor for greater COVID-19 severity and in-hospital death: a meta-analysis of observational studies. Nutr Metab Cardiovasc Dis. 2020;30(8):1236-48.15. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-62.16. Yıldırım OT, Kaya, Seyhmus. The atherogenic index of plasma as a predictor of mortality in patients with COVID-19. Heart Lung. 2021;50(2):329-33.17. Bellia A, Andreadi A, Giudice L, Taddeo SD, Maiorino A, D’Ippolito I, et al. Atherogenic dyslipidemia on admission is associated with poorer outcome in people with and without diabetes hospitalized for COVID-19. Diabetes Care. 2021;44(9):1-8.18. Agouridis AP, Pagkali A, Zintzaras E, Rizos EC, Ntzani EE. High-density lipoprotein cholesterol: A marker of COVID-19 infection severity? Atherosclerosis Plus. 2021;(44):1-9.19. Ormazabal V, Nair S, Elfeky O, Aguayo C, Salomon C, Zuñiga FA. Association between insulin resistance and the development of cardiovascular disease. Cardiovasc Diabetol. 2018;17(1):1–14.20. Al-Mahmood A, Afrin S, Hoque N. Dyslipidemia in insulin resistance: cause or effect. Bangladesh J Med Biochem. 2014;7(1):27–31.21. Li YW, Kao TW, Chang PK, Chen WL, Wu LW. Atherogenic index of plasma as predictors for metabolic syndrome, hypertension and diabetes mellitus in Taiwan citizens: a 9-year longitudinal study. Sci Rep. 2021;11(1):1–8.22. Sardu C, Gambardella J, Morelli MB, Wang X, Marfella R, Santulli G. Hypertension, thrombosis, kidney failure, and diabetes: Is covid-19 an endothelial disease? a comprehensive evaluation of clinical and basic evidence. J Clin Med. 2020;9(5):1-22.23. Masana L, Coeewig E, Ibarretxe D, Anoro E, Arroyo J, Jerico C, et al. Low HDL and high triglycerides predict COVID‑19 severity. Sci Rep. 2021;11(1):3-5.24. Peng F, Lei S, Zhang Q, Zhong Y, Wu S. Triglyceride/high-density lipoprotein cholesterol ratio is associated with the mortality of COVID-19: a retrospective study in China. Int J Gen Med. 2022;15:985-96.
Recommended Citation
Sastrawan, I Gede Gita; Upadhana, Putu Satyakumara; Handayani, Putu Novi; Laela, Tika Rizki Nur; Dewi, Kadek Aprilia Sukma; Wiguna, I Nyoman Bayu Andika; Trisna, Cindy Gracia; Putri, Komang Anjani; Agrasidi, Komang Adya Data; and Sudarmika, Putu
(2022)
"Atherogenic Index of Plasma is Correlated with Prolonged Length of Stay in COVID-19 Patients with Type 2 Diabetes Mellitus in RSUP Sanglah Denpasar,"
Jurnal Penyakit Dalam Indonesia: Vol. 9:
Iss.
2, Article 6.
DOI: 10.7454/jpdi.v9i2.784
Available at:
https://scholarhub.ui.ac.id/jpdi/vol9/iss2/6
